ISO 10993-4 Compliant Hemocompatibility Evaluation of Gellan Gum Hybrid Hydrogels for Biomedical Applications
2024

Evaluating Hemocompatibility of Gellan Gum Hydrogels

publication Evidence: moderate

Author Information

Author(s): Moyo Mthabisi Talent George, Adali Terin, Edebal Oğuz Han

Primary Institution: Girne American University

Hypothesis

The study investigates the hemocompatibility of gellan-gum-based hybrid hydrogels with varying concentrations.

Conclusion

Gellan-gum-based hydrogels, especially those with sodium alginate, show excellent hemocompatibility, while higher concentrations of gellan gum may lead to increased hemolytic activity.

Supporting Evidence

  • Gellan gum hydrogels showed faster swelling with sodium alginate than with silk fibroin.
  • Hydrogels with 0.3%, 0.5%, and 0.75% gellan gum exhibited normal hemocompatibility profiles.
  • 1% gellan gum formulations caused significant hemolytic and thrombogenic activity.
  • Surface morphology analysis indicated smoother surfaces with sodium alginate, enhancing hemocompatibility.

Takeaway

This study looks at how well certain gels made from gellan gum work with blood. Some gels are better than others at not causing problems when they touch blood.

Methodology

The study involved formulating hydrogels with different concentrations of gellan gum, silk fibroin, and sodium alginate, followed by swelling behavior analysis and hemocompatibility tests.

Limitations

The study did not directly assess complement activation, which is important for a complete evaluation of hemocompatibility.

Statistical Information

Statistical Significance

p ≤ 0.05

Digital Object Identifier (DOI)

10.3390/gels10120824

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication